Navigation Links
WHO to Investigate Hepatitis Vaccine Deaths in Vietnam

Viet Nam has suspended the use of a Hepatitis B vaccine manufactured by global leader LG group (the Republic of Korea ), after three newborn babies suddenly died after being administered with the vaccine.

The Health Ministry has immediately halted the use of the vaccine nation-wide while they ascertain the causes of the infants' deaths.

Since the vaccine is distributed through the World Health Organisation (WHO) channels, the agency is embarrassed and says it will investigate the deaths.

Hepatitis B is a serious disease caused by a virus that attacks the liver. The virus, which is called hepatitis B virus (HBV), can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death.

Hepatitis B vaccine is available for all age groups to prevent hepatitis B virus infection. Dr. Do Si Hien, Chairman of Vietnams National Vaccination Programme, said that between April 23 and May 7, a total of four infants went into shock after being given the vaccine. According to statistics, usually only one case of Hepatitis B vaccine shock is found for every one million people vaccinated against the disease, he added.

According to Hien, children under 12 months of age have been vaccinated against Hepatitis B under the national vaccination programme since 1997, with the programme expanding to all regions of the country by 2003. With close to 1.5 million children being vaccinated annually, Hepatitis B vaccine has been used on millions of Vietnamese children to date.

Hien urged parents to remain calm, saying that these were extremely unusual cases that related to only two batches of Hepatitis B vaccine manufactured by LG. The WHO said it supports, as a precautionary measure, the nationwide temporary suspension of the drug produced by South Korea's LG Life Sciences and distributed in Vietnam through a UN system.

The global health body has also "recommended the temporary suspension of the distribution and use of specific lots of the Euvax B vaccine produced by LG because of these recent reports," said WHO spokesperson Dida Connor.

Drugs from the same lots had been shipped to 24 countries, but no other adverse reactions had been reported to date from any of them, she said.

WHO will send a team of international experts to Vietnam as early as this week to investigate the cases, said Connor.

"WHO, Unicef and the government are taking this very seriously," she said. "We're making all efforts to ensure a full, prompt investigation.

"This doesn't mean that we have any information that is conclusive about the potential cause of this at this stage. WHO will send out further advice pending the outcome of this investigation."

Connor said the LG vaccine had been used for some years and that WHO had received no reports of deaths or serious reactions from any other countries.


'"/>




Related medicine news :

1. New Multi-functional Sensing Tool To Investigate Cystic Fibrosis
2. S.Africa Sets Up Task Team To Investigate Anthrax Outbreak In KNP
3. MMR- Autism- Bowel Problems Connection To Be Investigated
4. Researchers Investigate Protein that Protects Tumors
5. European Regulators Investigate Common Painkiller Drugs
6. Researchers Investigate Molecular Basis of Memory
7. Researchers Investigate Gene Linked With Circadian Liver Clock
8. Potential for Adult Stem Cells to Repair Hearts Damaged Investigated
9. CDA Investigates Case of Bovine Tuberculosis
10. Transplant Doctor Investigated in Organ Donor Case
11. Study to Investigate Genes Effect on Bone Loss in Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... CT (PRWEB) , ... March 29, 2017 , ... HealthCareMandA.com ... —on Thursday, April 20, 2017, at 1:00 PM ET. A recording of the webinar ... the Interactive Webinar Series. , Home health and hospice companies are still popular targets ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one ... cancers and is touted to be the next revolution in our fight against this ... in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , ...
(Date:3/29/2017)... PA (PRWEB) , ... March ... ... eastern suburbs and South Hills of Pittsburgh now have easier access to ... Pennsylvania only by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital ...
(Date:3/29/2017)... ... ... The Wharton School of the University of Pennsylvania is pleased to announce that ... gift to establish the Ken Moelis and Julie Taffet Moelis Advance Access Program ... for highly-qualified Penn undergraduates whose academic and career interests expand traditional notions of business ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 million SharePoint ... option for on-premises installation of its Help System for SharePoint was at the farm ... into the entire tenant. , The company recently released a modified version of ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets has ... Policy, Patients Treated at Proton Therapy Centers & Forecast" report to ... The South ... its current market size in 2016. The Untapped Proton Therapy Market for ... Billion USD in 2016. Proton Therapy plays an important ...
(Date:3/29/2017)... , Mar 29, 2017  Providence Medical ... announced the addition of two industry veterans to ... has joined the company to lead Global Marketing, ... leadership.  Together, Mr. Lynch and Mr. Scott have ... Mr. Lynch joins the company with ...
(Date:3/29/2017)...  Zynex (OTCQB: ZYXI), an innovative medical technology company specializing ... for pain management, stroke rehabilitation, cardiac monitoring and neurological ... 2016 full-year investor webcast on Monday, April 3, 2017 at 9:00 a.m. ... expects to file its 2016 full year financial results ... ...
Breaking Medicine Technology: